IDIX Stock Ownership Activity

IDENIX PHARMACEUTICALS LLC 13F holders

No value investing guru has made any change to the IDENIX PHARMACEUTICALS LLC (IDIX) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying IDIX now?

According to the latest SEC filing(s) IDENIX PHARMACEUTICALS LLC (IDIX) has not been purchased by any super investor.

To see more about who is investing in IDENIX PHARMACEUTICALS LLC (IDIX), please go to the IDIX ownership page.

2014 Q3 (2 results)
Prem Watsa
-100.00%
-50,400
-0.08%
0.00%
Seth Klarman
-100.00%
-53,331,109
-22.18%
0.00%
AVG reported price*: $23.95
2014 Q2 (1 result)
Prem Watsa
buy
+50,400
+0.08%
0.00%
Reported price*: $24.09
2014 Q1 (1 result)
Seth Klarman
+44.49%
+16,420,241
+2.25%
7.32%
Reported price*: $5.68
2013 Q4 (1 result)
Seth Klarman
+24.42%
+7,245,175
+1.23%
6.25%
Reported price*: $5.98
2013 Q3 (1 result)
Seth Klarman
+10.83%
+2,898,693
+0.43%
4.42%
Reported price*: $5.19
2013 Q2 (1 result)
Seth Klarman
buy
+26,767,000
+2.46%
2.46%
Reported price*: $3.61
7 of 7

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.